The global Hyperbaric Oxygen Therapy Devices Market size is expected to be valued at US$ 3.21 Billion in 2022. With the growing usage of hyperbaric oxygen therapy in wound healing, coupled with the increasing number of athletes resulting in demand for HBOT, the overall demand for Hyperbaric Oxygen Therapy Devices is projected to grow at a CAGR …
Category Archives: Healthcare Trends
Regenerative Artificial Skin Market is expected to reach a valuation of US$ 5,615.5 Million by 2032 | FMI
The global Regenerative Artificial Skin Market is expected to be valued at US$ 2,185.5 Million in 2022. This market is expanding because hospitals and clinics are increasingly in need of both temporary and permanent skin materials. The total demand for synthetic skin that is regenerative is anticipated to reach US$ 5,615.5 million in revenue by …
Mobile Cardiac Telemetry Systems Market is likely to grow to a valuation of US$ 2,872.05 Million by 2032 | FMI
The global Mobile Cardiac Telemetry Systems market will witness a stellar CAGR of 11.9% from 2022 to 2032. The target market will likely reach a valuation of US$ 2,872.05 million by 2032 as opposed to US$ 933.02 million in 2022. The rising incidences of cardiovascular disorders (CVDs) and associated mortality have generated greater awareness regarding …
HER2 Positive Gastric Cancer Market is predicted to reach a valuation of US$ 1779.8 Million by 2033
The global HER2 Positive Gastric Cancer Market is currently valued at US$ 1261.8 million in 2023, with a CAGR of 3.5% expected. Because of technological advancements in healthcare, the market is expected to reach US$ 1779.8 million by 2033. “Increased disease burden and pipeline candidate approval are likely to drive the growth of the HER2 …
Neurological Biomarkers Market is expected to reach a valuation of US$ 12.5 Billion by 2033 | FMI
The global Neurological Biomarkers Market is projected to have a high-paced CAGR of 4.6% during the forecast period. The current valuation of the neurological biomarkers market is US$ 8 Billion in 2023. The value of the neurological biomarkers market is anticipated to reach a high of US$ 12.5 Billion by the year 2033. The key …
Intrauterine Insemination Devices Market is expected to be valued at US$ 57.5 million by 2033 | FMI Analyst
The global Intrauterine Insemination Devices Market is expected to be valued at US$ 40.5 million in 2023 and reach a valuation of US$ 57.5 million by 2033. The demand for intrauterine insemination devices is estimated to grow at a steady 3.6% CAGR. The growing awareness about fertility treatments and infertility is driving demand for intrauterine …
High Flow Nasal Cannula Market is forecast to be worth US$ 17.7 Billion by 2030 | FMI Study
High Flow Nasal Cannula Market is anticipated to increase at a CAGR of 11.6% between 2022 and 2030. The market for high-flow nasal cannulas is expected to grow from US$ 7.37 billion in 2022 to US$ 17.7 billion in 2030. High-flow nasal cannula sales currently account for a 35.9% share of the global respiratory care …
Eisenmenger Complex Management Market to reach US$ 12.9 billion in 2033
The global Eisenmenger complex management market is expected to surpass an impressive valuation of US$ 7.7 billion in 2023 and is projected to reach US$ 12.9 billion by 2033, growing at a CAGR of 5.3%. Generally, the treatment includes relieving the symptoms and associated co-morbidities. Medications such as calcium channel blockers, antiarrhythmic agents, and blood thinning agents …
Continue reading “Eisenmenger Complex Management Market to reach US$ 12.9 billion in 2033”
Head and Neck Cancer (HNC) Therapeutics market is forecast to reach US$ 5.19 Billion by 2033, growing at a CAGR of 12.6% until 2033
The global Head and Neck Cancer (HNC) Therapeutics market is anticipated to surpass a remarkable worth of US$ 1.58 Billion in 2023, with a compound annual growth rate (CAGR) of 12.6% from 2023 to 2033. Developments in the detection and treatment of head and neck cancer (HNC) are expected to propel market expansion as they are less …
Filariasis Treatment Market to reach US$ 28.68 Billion by 2033, Drugs to account for Bulk of all Treatments | FMI Study
According to Future Market Insights, global filariasis treatment is expected to grow at a CAGR of 10.1% between 2023 and 2033, reaching US$ 28.68 billion in 2033. The increasing prevalence of filariasis and improved diagnostic capabilities are expected to drive growth in the filariasis treatment market. The availability of effective treatments and awareness of the disease is …